Administration of semaglutide before metabolic and bariatric surgery does not confer benefits for overall weight loss, ...

A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...

Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme. REDEFINE 2 is a 68 ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

A study by Mass General Brigham found that taking the weight-loss drug semaglutide before bariatric surgery does not lead to ...

Semaglutide — the type 2 diabetes and weight loss medication sold under the brand names Ozempic and Wegovy — can expire. If ...

Stanford researchers have discovered BRP, a naturally occurring peptide that suppresses appetite and promotes weight loss, ...

HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...